Activity of lysosomal exoglycosidases in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis

References

• Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004; 113: 1093–101
   PubMed Web of Science ®Google Scholar
• Berenbaum F, Le Gars L, Toussirot E, Sanon A, Bories C, Kaplan G, et al. Marked elevation of serum N-acetyl-beta-D-hexosaminidase activity in rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 63–6
   PubMedGoogle Scholar
• Ortutay Z, Polgàr A, Gömör B, Geher P, Lakatos T, Glant TT, et al. Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion. Arthritis Rheum 2003; 8: 2163–72
   Google Scholar
• Shikhman AR, Brinson DC, Lotz M. Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation. Arthritis Rheum 2000; 43: 1307–14
   PubMed Web of Science ®Google Scholar
• Pancewicz SA, Wielgat P, Hermanowska-Szpakowicz T, Kondrusik M, Zajkowska J, Grygorczuk S, et al. Activity of lysosomal exoglycosidases in serum of patients with chronic Lyme arthritis. Int J Med Microbiol 2006; 296: 280–2
   PubMedGoogle Scholar
• Popko J, Marciniak J, Zalewska A, Górska A, Zwierz K, Sierakowski S, et al. Activity of N-acetyl-β-hexosaminidase and its isoenzymes in serum and synovial fluid from patients with different arthropathies. Clin Exp Rheumatol 2006; 24: 690–3
   PubMedGoogle Scholar
• Zwierz K, Gindzienski A, Glowacka D, Porowski T. The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung 1981; 38: 145–52
   PubMedGoogle Scholar
• Marciniak J, Zalewska A, Popko J, Zwierz K. Optimization of an enzymatic method for the determination of lysosomal N-acetyl-beta-D-hexosaminidase and beta-glucuronidase in synovial fluid. Clin Chem Lab Med 2006; 44: 933–7
   PubMedGoogle Scholar
• Shin JJ, Glickstein LJ, Steere AC. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of anti biotic-refractory Lyme arthritis. Arthritis Rheum 2007; 56: 1325–35
   PubMedGoogle Scholar
• Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999; 12: 633–53
   PubMed Web of Science ®Google Scholar
• Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, et al. An epidemiological study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319–27
   PubMed Web of Science ®Google Scholar
• Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 2003; 48: 534–40
   PubMedGoogle Scholar
• Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281: 703–6
   PubMed Web of Science ®Google Scholar
• Pachner AR, Cadavid D, Shu G, Dail D, Pachner S, Hodzic E, et al. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol 2001; 50: 330–8
   PubMedGoogle Scholar
• Pachner AR, Basta J, Delaney E, Hulinska D. Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy. Am J Trop Med Hyg 1995; 52: 128–33
   PubMedGoogle Scholar
• Straubinger RK, Straubinger AF, Härter L, Jacobson RH, Chang YF, Summers BA, et al. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun 1997; 65: 1273–85
   PubMed Web of Science ®Google Scholar
• Leong JM, Wang H, Magoun L, Field JA, Morrissey PE, Robbins D, et al. Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun 1998; 66: 994–9
   PubMedGoogle Scholar
• Parveen N, Robbins D, Leong JM. Strain variation in glycosaminoglycan recognition influences cell-type-specific binding by Lyme disease spirochetes. Infect Immun 1999; 67: 1743–9
   PubMedGoogle Scholar
• Fischer JR, Le Blanc KT, Leong JM. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect Immun 2006; 74: 435–41
   PubMedGoogle Scholar
• Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, Cabello FC. Borrelia burgdorferi binds to, invades, and colonizes native type 1 collagen lattices. Infect Immun 2004; 72: 3138–46
   PubMedGoogle Scholar
• Heroldová M, N(mec M, Hubálek Z, Halouzka J. Enzyme activities of Borrelia burgdorferi sensu lato. Folia Microbiol (Praha) 2001; 46: 179–82
   PubMed Web of Science ®Google Scholar
• Akin E, Aversa J, Steere AC. Expression of adhesion molecules in synovia of patients with treatment-resistant Lyme arthritis. Infect Immun 2001; 69: 1774–80
   PubMedGoogle Scholar
• Pugh D, Walker PG. The localization of N-acetyl-beta-glucosaminidase in tissues. J Histochem Cytochem 1961; 9: 242–50
   PubMed Web of Science ®Google Scholar
• Popko J, Marciniak J, Zalewska A, Maldyk P, Rogalski M, Zwierz K. The activity of exoglycosidases in the synovial membrane and knee fluid of patients with rheumatoid arthritis and juvenile idiopatic arthritis. Scand J Rheumat 2006; 35: 189–92
   PubMed Web of Science ®Google Scholar
• Schoen RT, Aversa JM, Rahn DW, Steere AC. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 1991; 34: 1056–60
   PubMed Web of Science ®Google Scholar